Ładuje się......
Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have become a treatment option in non-small-cell lung cancer (NSCLC) patients. However, despite their use in this disease, a significant number of patients will eventually develop resistance and relapse. In this...
Zapisane w:
Główni autorzy: | , , , , , , , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
BioMed Central
2012
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3533816/ https://ncbi.nlm.nih.gov/pubmed/22992338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-31-77 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|